Clinical Trial Update: Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cytokine-induced killer (CIK) cell therapy for patients with refractory non-Hodgkin lymphoma; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CIK cell therapy (cytokine-induced killer cells)

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: NOT_YET_RECRUITING